Tamara Fong

Dr. Tamara Fong

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2009 in Nature Reviews Neurology
Verified
Journal Article
Closed access
PDF file
TFTamara Fong
Tamara Fong
STSamir R. Tulebaev
Samir R. Tulebaev
SISharon K. Inouye
Sharon K. Inouye

5 May 2009 in Neurology
Verified
Journal Article
Closed access
PDF file
TFTamara Fong
Tamara Fong
RJR. N. Jones
R. N. Jones
PSP. Shi
P. Shi
EME. R. Marcantonio
E. R. Marcantonio
LYL. Yap
L. Yap
SIS. K. Inouye
S. K. Inouye
Objective: To examine the impact of delirium on the trajectory of cognitive function in a cohort of patients with Alzheimer disease (AD). Methods: A secondary analysis of data collected from a large prospective cohort, the Massachusetts Alzheimer’s Disease Research Center’s patient registry, examined cognitive performance over time in patients who developed (n = 72) or did not develop (n = 336) delirium during the course of their illnesses. Cognitive performance was measured by change in score on the Information-Memory-Concentration (IMC) subtest of the Blessed Dementia Rating Scale. Delirium was identified using a previously validated chart review method. Using linear mixed regression models, rates of cognitive change were calculated, controlling for age, sex, education, comorbid medical diagnoses, family history of dementia, dementia severity score, and duration of symptoms before diagnosis. Results: A significant acceleration in the slope of cognitive decline occurs following an episode of delirium. Among patients who developed delirium, the average decline at baseline for performance on the IMC was 2.5 points per year, but after an episode of delirium there was further decline to an average of 4.9 points per year (p = 0.001). Across groups, the rate of change in IMC score occurred about three times faster in those who had delirium compared to those who did not. Conclusions: Delirium can accelerate the trajectory of cognitive decline in patients with Alzheimer disease (AD). The information from this study provides the foundation for future randomized intervention studies to determine whether prevention of delirium might ameliorate or delay cognitive decline in patients with AD.

26 August 2022 in Nature Reviews Neurology
Verified
Journal Article
Closed access
PDF file
TFTamara Fong
Tamara Fong
SISharon K. Inouye
Sharon K. Inouye

3 August 2009 in Alzheimer's & Dementia
Verified
Journal Article
Closed access
TFTamara Fong
Tamara Fong
MFMichael A. Fearing
Michael A. Fearing
RJRichard N. Jones
Richard N. Jones
PSPeilin Shi
Peilin Shi
EMEdward R. Marcantonio
Edward R. Marcantonio
SISharon K. Inouye
Sharon K. Inouye

19 June 2012 in Annals of Internal Medicine
Verified
Journal Article
Closed access
TFTamara Fong
Tamara Fong
RJRichard N. Jones
Richard N. Jones
EMEdward R. Marcantonio
Edward R. Marcantonio
DTDouglas Tommet
Douglas Tommet
AGAlden L. Gross
Alden L. Gross
SISharon K. Inouye
Sharon K. Inouye
Hospitalization can have devastating consequences for patients with Alzheimer disease. In this large prospective registry of patients with Alzheimer disease, hospitalization was associated with a s... Background: Hospitalization, frequently complicated by delirium, can be a life-changing event for patients with Alzheimer disease (AD). Objective: To determine risks for institutionalization, cogni...

1 December 2006 in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
Verified
Journal Article
Open access
PDF file
TFTamara Fong
Tamara Fong
SBSidney T. Bogardus
Sidney T. Bogardus
ADAditya Daftary
Aditya Daftary
EAEliza Auerbach
Eliza Auerbach
HBHal Blumenfeld
Hal Blumenfeld
SISharon K. Inouye
Sharon K. Inouye
Background. Prior studies describe variable cerebral blood flow changes in delirium. This study aims to investigate cerebral blood flow changes in older hospitalized patients with delirium, the population in which most cases of delirium occur. Methods. Participants included hospitalized general medical patients aged 65 years and older with documented delirium and no relevant medical conditions or preexisting abnormalities on neuroimaging prospectively studied using 99mTc HMPAO single photon emission computed tomography (SPECT) scans obtained during and after resolution of delirium. Twenty-two patients enrolled in the study, of whom six completed both scans. All participants underwent neuropsychological assessment immediately prior to SPECT scanning. SPECT images were compared across all participants during delirium; for patients completing paired scans, within-patient comparisons were made. Results. Visual assessment of SPECT scans revealed perfusion abnormalities in frontal (5 participants) or parietal regions (6 participants); scans were normal in 11 participants (50%). Region-of-interest analysis identified reduced blood flow (p <.01) in the left inferior frontal, right temporal, right occipital, and pontine regions. Analysis of paired scans revealed reversible abnormalities in three participants (p <.001), with decreased right parietal perfusion in two participants and increased left parietal perfusion in one participant. Conclusions. The results of this study of a small group of general medical patients are suggestive that frontal or parietal cerebral perfusion abnormalities occur in delirium, and these findings need to be confirmed by future, larger studies. These results may help to improve basic understanding of delirium pathophysiology, to identify long-term changes, and to evaluate response to treatment over time.